LIGAND PHARMACEUTICALS INC CON COM

LIGAND PHARMACEUTICALS INC CON COM is a security (CUSIP 532CNT029) tracked across SEC portfolio filings. 1 institutional managers reported positions on Form 13F as of 2026-06-30; 2 registered fund positions totaling $0 via N-PORT as of 2026-05-29.

Summary

• Issuer: LIGAND PHARMACEUTICALS INC CON
• Class: COM
• CUSIP: 532CNT029
• Asset category: EC
• 13F holders: 1
• 13F period: 2026-06-30
• N-PORT fund positions: 2
• N-PORT value: $0
• N-PORT report: 2026-05-29

Top institutional holders (Form 13F)

Top fund holders (N-PORT)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search